Susceptibility weighted imaging (SWI) is a recently developed magnetic resonance imaging (MRI) technique that is increasingly being used to narrow the differential diagnosis of many neurologic disorders. It exploits the magnetic susceptibility differences of various compounds including deoxygenated blood, blood products, iron and calcium, thus enabling a new source of contrast in MR. In this review, we illustrate its basic clinical applications in neuroimaging. SWI is based on a fully velocity-compensated, high-resolution, three dimensional gradientecho sequence using magnitude and phase images either separately or in combination with each other, in order to characterize brain tissue. SWI is particularly useful in the setting of trauma and acute neurologic presentations suggestive of stroke, but can also characterize occult low-flow vascular malformations, cerebral microbleeds, intracranial calcifications, neurodegenerative diseases and brain tumors. Furthermore, advanced MRI post-processing technique with quantitative susceptibility mapping, enables detailed anatomical differentiation based on quantification of brain iron from SWI raw data. Core tip: Susceptibility weighted imaging has a variety of applications in neuroradiology practice and should be included in routine protocols. It can detect microand macrohemorhages and delineate cerebral microvasculature and can also reveal low-flow vascular malformations. It has been proven as a complementary, valuable imaging sequence in the management of stroke patients. It provides differentiation of calcium from hemorrhage in the brain. It plays an important role in the evaluation of traumatic brain injury patients and aids in the characterization and grading of cerebral tumors. 
INTRODUCTION
Susceptibility weighted imaging (SWI) is an magnetic resonance imaging (MRI) technique that exploits the ma gnetic susceptibility differences of various compounds, such as blood, iron, and diamagnetic calcium, thus en abling new sources of MR contrast [13] . SWI has been shown to provide clinically useful co mplementary information to conventional spinecho MRI sequences. Additionally, through postprocessed quant itative susceptibility mapping (QSM) SWI sequences allow data driven research to evaluate compounds that alter the magnetic field of the brain, a strategy most useful in neurodegenerative disorders. In this review, we highlight many clinical applications of SWI in the evaluation and differential diagnosis of diverse central nervous system (CNS) pathologic conditions. We close with an asse ssment of the future of SWI and QSM.
PRINCIPLES AND TECHNICAL ASPECTS OF SWI
Local magnetic field heterogeneity leading to T2 sh ortening may be induced by paramagnetic, diamagnetic and ferromagnetic substances and results in signal loss on T2* weighted gradientecho (GE) sequences (proton relaxation enhancement). The susceptibility effect is most visible in nonrefocused GE techniques using long echo times (TE), short flip angles, and high field strengths. Although SWI relies on GE sequences, it has enhanced susceptibility sensitivity compared with conventional T2* weighted GE sequences because it is based on a high-resolution, long TE, flow-compensated, 3D GE imaging technique containing filtered phase information in each voxel [4] . In SWI, the magnitude and phase MR data are brought together and a phase mask is created. Multiplying these with the original magnitude images result in a final magnitude SWI dataset. Both magnitude and phase information are essential for proper tissue characterization, and are brought together to create an SWI image [5] . Finally, these images are further processed with a minimum intensity projection algorithm (minIP) to obtain 310 mm thick high signal to noise minIP slabs. These minIP images thereby re veal the continuity of tortuous veins across the slices while attenuating the signal coming from the brain tis sue [4] . On magnitude images, the longer TE of the SWI sequence (e.g., 40 ms at 1.5 tesla) compared with co nventional GE sequences (TE 25 ms) allows for more phase dispersion and T2 shortening of the protons in the local inhomogenous magnetic field. Thus SWI highlights small changes in susceptibility across a voxel as signal intensity loss. A low flip angle can keep the CSF brighter than the surrounding parenchyma. Consequently, the magnitude image highlights areas with short T2* and leads to lower signal in major veins due to the presence of deoxyhemoglobin [6] . SWI sequence parameters for 1.5 and 3 Tesla Siemens (Erlangen, Germany) and Philips (the Netherlands) magnets are shown in Tables 14.
Paramagnetic materials have at least one unpaired electron in the system, but diamagnetic materials have all their electrons paired. Diamagnetic materials are repelled by a magnetic field; an applied magnetic field creates an induced magnetic field in them in the opposite direction, causing a repulsive force. In contrast, paramagnetic and ferromagnetic materials are attracted by a magnetic field. Oxyhemoglobin is diamagnetic in nature, whereas deoxyhemoglobin is paramagnetic. The paramagnetic deoxyhemoglobin serves as an in trinsic contrast agent on SWI sequences, and is low in signal. This causes magnetic field inhomogeneity due to two effects: A reduction of T2* and a phase difference between the vessel and its surrounding tissue. This property also forms the basic principle for blood oxygen level dependent functional and venographic imaging.
Paramagnetic substances display positive phase shift in lefthanded MR systems such as the Avanto system of Siemens magnets (Erlangen, Germany). Hence, the phase images are particularly useful for differentiating between paramagnetic susceptibility effects of blood products such as deoxygenated hemoglobin, intra cellular methemoglobin, hemosiderin and ferritin (positive shift) and diamagnetic effects of calcium (negative or no shift) [7, 8] . Unfortunately, ferrocalcinosis may lead to confusing signal intensity patterns as even basal ganglia "calcification" is often a mixture of paramagnetic iron and diamagnetic calcium. Yamada et al [8] demonstrated that all basal ganglia calcifications show a paramagnetic susceptibility effect, whereas other calcifications located outside the basal ganglia (such as choroid plexus or dural calcifications) exhibit exclusively a diamagnetic susceptibility effect. Iron accumulation in brain not only occurs in aging but is also encountered in diverse neur odegenerative diseases. SWI sequences have some intrinsic disadvantages. Undesirable magnetic susceptibility sources that cause artifacts occuring at airtissue interfaces such as the areas adjacent to the temporal bone and sinuses limit investigation of these regions. Also the blooming ar tifact, a useful sign for detecting sources of field inh omogeneity, may sometimes lead to extreme tissue signal cancellation and loss of anatomical borders [4] .
CLINICAL APPLICATIONS

Cerebral amyloid angiopathy
Cerebral amyloid angiopathy (CAA) is a small vessel disease characterized by amyloid β protein deposition within the cerebral arterioles leading to fibrinoid necrosis and vessel fragility. CAA causes microhemorrhages in and around the arteriole vessel wall extending into the parenchyma [9] . CAA is a major cause of primary lobar intracranial hemorrhage and cerebral microhemorrhages in the elderly [10] . CT and routine MRI techniques are us ually not able to detect cerebral microbleeds; however, SWI with its unique sensitivity to susceptibility effects, clearly demonstrates lobar and microhemorrhages predominantly in the frontal and parietal cortical and subcortical regions (Figure 1 ). In contrast, microhe morrhages resulting from hypertensive or atheros clerotic microangiopathy have a predilection of deep gray matter or the infratentorial location ( Figure 2 ). CAA is also manifested by white matter hyperintensities on MRI sequences which may be accompanied clinically by cognitive impairment [11] . Detection of two or more lobar hemorrhages of any duration, high signal intensity changes in the white matter and multiple cerebral mic robleeds at the corticomedullary junction are highly suspicious for CAA (10) (Figure 1 ). Linn et al [12] have highlighted the presence of hemosiderosis on the pial surface of the brain, likely from the leakage of blood products from repetitive superficial hemorrhages in as much as 35% of CAA cases.
Hypertensive cerebral angiopathy
Hypertensive cerebral angiopathy may also be char acterized by multiple silent cerebral microhemorrhages. Unlike CAA, cerebral microhemorrhages associated with chronic systemic hypertension are more commonly found in the thalamus, basal ganglia, cerebellum and pons [10] ( Figure 2 ). These hypertensive cerebral microhemorrhages are a risk factor for development of a subsequent in tracerebral macrohematomas/lobar hemorrhages [13] . The number of cerebral microhemorrhages corresponds also with blood pressure levels. Such microand macrohemorrhages are exquisitely welldemonstrated by SWI particularly with acute deoxyhemoglobin or chronic hemosiderin.
TRAUMATIC BRAIN INJURIES
Diffuse axonal injury (DAI) is a type of traumatic brain injury, in which torsional forces generated by rapid acceleration or deceleration of the head cause shearing of axons. Areas most vulnearable to shear injury include the cerebral graywhite matter junction, splenium of the corpus callosum, basal ganglia and dorsolateral brainstem [10] . The extent of the axonal injury has been shown to correlate with a poor prognosis, as do par enchymal hemorrhages [14] . Recent studies have shown that SWI is more sensitive than CT or GE sequences in terms of detecting suspected hemorrhagic DAI [15] . Most DAI patients have small punctate hemorrhages located in the deep subcortical white matter [16] (Figure 3 ). Tong et al [17, 18] and Babikian et al [19] demonstrated that SWI is 36 times more sensitive than T2* GE sequences in terms of detecting the number, size, volume and distribution of hemorrhagic lesions seen in DAI cases. Halefoglu AM et al .
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Because of this, the previously held concept of "nonhe morrhagic shearing injury" has largely been debunked. Those formerly "bland lesions" of DAI are now shown to have microbleeds on SWI. Brain stem involvement in DAI patients is also a very important predictor that determines the longterm outcome [20] . Mittal et al [16] demonstrated that SWI was more helpful in detecting traumatic lesions occuring in the brainstem than any other MRI sequence, and revealed intraventricular and subarachnoid hemorrhage, invisible on CT. Long term hemosiderosis from recurrent traumatic bleeds (which may occur in nonaccidental trauma) is also best de tected on SWI. Epidural and subdural hematomas can also be demonstrated well on SWI sequences as long as airbone interfaces do not lead to masking artifacts.
CNS VASCULAR MALFORMATIONS
True arteriovascular malformations (AVMs) usually are present at birth and can become large with time. These AVMs are characterized by their highflow and therefore can usually be detected by conventional MRI/ MR angiography techniques. In contrast, lowflow vas cular malformations including cerebral cavernous ma lformations (CCMs), developmental venous anomalies (DVAs) and CaTe (capillary telengiectasias) may be in apparent on fast spin echo (FSE) MRI/MR angiography techniques because they mainly contain slowflow small vessels. Although T2* weighted GE imaging is capable of detecting small venous structures and hemosiderin deposition in cavernomas and CaTes, the incorporation of the magnitude and phase information in SWI provides improved sensitivity for identifying low flow vascular malformations that are undetectable on GE sequences [21, 22] . Lee et al [21] showed that SWI is the ideal imaging sequence for screening patients who have a high clinical suspicion of low-flow vascular malformations. These lesions may be responsible for cryptogenic Halefoglu AM et al . SWI of brain diseases epilepsy, recurrent subarachnoid hemorrhage and/or hemosiderosis, and hemorrhagic injury to cranial nerves. Because the incidence of hemorrhage from occult cer ebrovascular malformations is contingent on whether they have ever bled, using SWI to detect previous ble eding helps prognosticate on future risk [23] . CCMs are composed of abnormally enlarged capillary cavities surrounded by a single layer of endothelium wit hout intervening with brain parenchyma and comprise 10%20% of all cerebrovascular malformations [24] . The MRI findings of CCMs are variable, depending on the presence of calcification and hemorrhage within the lesions, but they typically show a mixed signal intensity, usually recognized as "popcornlike" with a central reticulated core surrounded by a peripheral rim of hemosiderin [15] ( Figure   4 ). Since recurrent microhemorhages occur in the CCM lesions, they may contain deoxyhemoglobin acutely or hemosiderin chronicly, both dark on SWI [25, 26] ( Figure 5 ).
Symptomatic, growing and recurrently hemorrhagic CCMs are considered for surgical resection. DVAs are the most common type of cerebral vascular malformations (≤ 60%) and are often discovered incid entally during routine MRI examinations [27] . A DVA consists of radially arranged venous structures converging to a centrally located venous trunk, which drains normal brain parenchyma [28] . They are mainly asymptomatic lesions, do not often bleed, and neurosurgical intervention is largely contraindicated due to the risk of venous infarction [29] . However, they have a high association with other vascular malformations, especially CCMs. SWI better shows the collector (head of Medusa) and deep medullary veins (snake hair of Medusa) than T1W contrast enhanced images by virtue of the low intensity of the dark veins on miniIP images ( Figure 6 ).
CaTes are asymptomatic small vascular malformations typically ranging from several milimeters to 2 cm in size, primarly found in the pons. They may occur sporadically or may be seen with syndromes like hereditary hemorrhagic telangiectasia or after radiation therapy [30] . They are characterized by faint contrast enhancement on T1W images and therefore can be easily missed. On SWI, they can be readily identified as hypointense lesions, from deoxyhemoglobin or hemosiderin deposited in this low flow vascular malformation ( Figure 7) .
SturgeWeber syndrome (SWS) is a neurocutaneous disorder, typically seen in children and characterized by a cutaneous angioma, glaucoma and leptomeningial venous angiomatosis [31] . The imaging findings consist of unilateral cerebral atrophy, cortical "tramtrack" calcifications, impaired cortical venous outflow and abnormal deep Halefoglu AM et al . SWI of brain diseases venous collaterals. SWI has been found to be superior to post gadoliniumenhanced T1WI in characterizing calcification, abnormal periventricular and transmedullary veins, cortical gyriform hypointensities and graywhite matter abnormalities (Figure 8 ) [22] , but enhanced T1W images depict the leptomeningial angiomatosis and enlarged choroid plexus more clearly.
Cerebral venous sinus thrombosis and venous infarction
Patients with cerebral venous sinus thrombosis (CVST) may present with headaches or nonspecific signs due to increased intracranial pressure (ICP). Remaining undiagnosed, it can become deadly if it progresses to malignant increased ICP [32] . An acute CVST shows deoxyhemoglobin in the involved veins, seen as prominent hypointense signal intensity areas with "blooming" artifact on SWI (Figure 9 ). SWI may demonstrate engorgement of the venous system as an early sign of CVST and can also show the associated parenchymal hemorrhage which occurs in 73% of venous infarctions [33] . 
ARTERIAL STROKE
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by decreasing the arterial flow, and increases pooling of deoxygenated blood, thus leading to a high concentration of deoxyhemoglobin [34] . In the setting of acute stroke, such conversion to deoxhyhemoglobin can occur as early as 2 h after the onset of symptoms.
In the setting of stroke, SWI assists in identifying: (1) Hemorrhages within the infarct region, thus ena bling the differentiation of a hemorrhagic from a bl and ischemic stroke. Many studies have also proven that SWI is more sensitive in revealing hemorrhage within the acute infarct regions than CT and 2D GE T2* weighted sequences [35, 36] . SWI can also detect ac ute subarachnoid hemorrhage and is very sensitive to subacute and chronic subarachnoid hemorrhages, sometimes missed by CT and FLAIR [3] ( Figure 10) ; (2) Prominent hypointense draining veins within areas of impaired perfusion ( Figure 11 ). The visualization of these prominent veins allows for the identification of diffusionperfusion mismatch representing penumbral brain tissue in a different fashion than current perfusion weighted imaging techniques [16] . The oxygen extraction fraction (OEF) which reflects the ratio of deoxyhemoglobin to Halefoglu AM et al . SWI of brain diseases oxyhemoglobin in the capillaries and veins, is significantly increased in the penumbra following occlusion of the artery. This high OEF in cortical veins is presumably responsible for the increased conspicuity in the infarct region [30, 36] ; (3) Acute intra-arterial thrombus: The susceptibility vessel sign (SVS) is defined as the presence of hypointensity from scute deoxyhemoglobin thrombus within the intracranial arteries in which the diameter of the hypointense vessel exceeds the contralateral vessel diameter [37, 38] (Figures 12 and 13 ). Lingegowda et al [39] found an 82% sensitivity and 100% specificity for the SVS in the determination of all acute major intracranial occlusions. They also showed that SVS is more sensitive and specific than the hyperdense artery sign on CT [40, 41] and the hyperintense vessel sign on FLAIR images for intracranial artery occlusions. Huang et al [42] found that patients with negative prominent veins and positive susceptibility vessel sign exhibited poor outcomes; and (4) Halefoglu AM et al . SWI of brain diseases within the first week after a stroke [43] (Figure 14) . Old microhemorrhages in a stroke patient may presage the vulnerability of the vascular system [44] . In patients with a small number of microhemorrhages (< 5), thrombolytic therapy can be applied safely, whereas patients with large numbers of microhemorrhages (> 5) have a great risk for potential hemorrhagic transformation from thrombolytic therapy [4549] . Huang et al [42] showed that microhemorrhages were significantly associated with later hemorrhagic transformation. SWI is able to detect microhemorrhages within the infarct region more accurately than T2* weighted GE sequences.
NEURODEGENERATIVE DISEASES
It is widely accepted that iron deposition in the brain increases with normal aging, particularly in the basal ganglia region primarily in the form of ferritin and ferrocalcinosis ( Figure 15 ). Increased iron levels in the CNS are encountered in a variety of neurodegenerative Halefoglu AM et al . SWI of brain diseases diseases, superimposed on the normal senescent iron increase [50, 51] in the globus pallidum, substantia nigra, red nucleus, subthalamic nucleus and dentate nucleus. Increased iron deposition is found in Parkinson's disease, Huntington's disease, Alzheimer's disease, Multiple sclerosis (MS), Amyotrophic lateral sclerosis, HallervordenSpatz syndrome, Wilson's Disease (copper) and Pantothenate kinaseassociated neurodegeneration (PKAN) [52] (Table 5) . In neurodegenerative diseases, the ability to measure the amount of ferritin in the brain may help predict prognosis, disease progression and treatment outcomes. SWI shows differences in stable and progressive MCI [57] . Fourteen percent of controls, 33% of patients with stable MCI and 54% of those with progressive MCI had microhemorrhages. Furthermore, the iron content in the right pallidum and right substantia nigra was greater in progressive MCI than stable MCI.
Barnaure et al [58] studied 328 cognitively normal control subjects and 71 patients with MCI using SWI on a 3T magnet to investigate the presence and distribution of cerebral microbleeds. They found no difference be Halefoglu AM et al . SWI of brain diseases tween the two groups in terms of cerebral microbleed prevalence, distribution and severity. The patients' cognitive decline over an 18 mo period did not correlate with microbleeds. They concluded that microbleeds do not predict cognitive decline in advanced age. MS affects both brain and spinal cord and is typically imaged with FLAIR and contrastenhanced T1W images. The sensitivity of MRI in depicting MS lesions in the brain is demonstrated to be high, but its specificity remains low. SWI helps by revealing the perivenular distribution of the demyelinating lesions by showing the MS plaque surrounding the small veins [59] . This has been used to distinguish MS from SAPHO (synovitis, acne, pustulosis, hyperostosis and osteitis) syndrome white matter lesions.
Rudko et al [61] have shown that the levels of iron deposition in patients with MS correlates better with disability than MS plaque volume. They have also shown increased iron content in patients with clinically isolated syndrome (CIS).
BRAIN TUMORS
SWI can help in the grading of cerebral tumors because it provides identification of both hemorrhagic and calcified foci inside the tumors and also allows assessment of the detailed internal angioarchitecture of the tumors. High grade tumors like glioblastomas usually contain a hemorrhagic component ( Figure 16 ) [3, 6264] . Sehgal et al [65] demonstrated that in the majority of cases, SWI was equivalent to T1W contrastenhanced images in the grading of gliomas. The criteria used for this comparison were tumor visibility, boundaries, ede ma, vessels, blood products, internal architecture and image quality. Mittal et al [16] have showed that high rCBV values on PWI and high cholinecreatine ratios on MR sp ectroscopy found in tumors exhibit a good correlation with evidence of blood products demonstrated within the tumor using SWI.
In assessing brain tumors, calcification is considered as a very important indicator. Calcification is diamagnetic, whereas hemorrhage is paramagnetic, therefore resulting in opposite signal intensities on SWI phase images [66] . For the determination of calcification in brain tumors such as oligodendrogliomas, Zulfigar et al [67] found that adding SWI sequences led to a statistically significant improvement in the sensitivity for the detection of in tratumoral calcification by 53% (from 33% to 86%) but no change in specificity. SWI can also be used to distinguish vestibular sch wannomas from cerebellopontine angle meningiomas. Figure 15 A 79-year-old woman with Alzhemier's disease. A: SWI minIP image shows hypointense signal intensity in the globus pallidus and putamen indicating increased iron deposition; B: SWI phase image reveals hyperintense signal in the basal ganglia due to the positive shift effect of paramagnetic iron. SWI: Susceptibility weighted imaging; minIP: Minimum intensity projection algorithm. Halefoglu AM et al .
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Microhemorrhages occur with schwannomas, not found in the meningiomas [68] (Figure 17 ).
The dual rim sign (hyperintense inner, hypiointense outer) from the respiratorty burst of bacteria converting hemoglobin to methemoglobin has been shown to differentiate abscesses (present) from glioblastoma (absent) in the face of a ring enhancing mass [69] .
QSM
QSM is a recently developed sophisticated postpro cessing technique and numerically solves the inverse sourceeffect problem to quantify local tissue magnetic susceptibility from the major magnetic field distribution, reflected in the phase images of SWI [70] . The mapping of iron can play a crucial role in the setting of many important neurologic disorders. In early Parkinson's disease (PD), iron elevation in the specific brain regions including the substantia nigra is a pathognomonic fe ature of the disease and this can be measured by QSM [71] . He et al [72] evaluated 44 early PD patients; susceptibility values within the substantia nigra and red nucleus contralateral to the most affected limb were elevated compared to a healthy control group. Bilateral substantia nigra magnetic susceptibility showed a posit ive correlation with disease duration [72] . AcostaCabronero et al [73] examined 66 patients with idiopathic PD and found increased R2* and susceptibility values in the substantia nigra, red nucleus, thalamus and globus pallidus. QSM additionally correlated with disease severity in these patients. Moon et al [74] investigated the presence and pattern of brain iron accumulation in vascular dementia (VaD) and Alzheimer's disease (AD) patients by means of QSM. Both in VaD and AD patients significantly higher susceptibility values were found in the caudate nucleus and putamen compared to control subjects. Age and cognitive disease severity of both patient groups were not correlated with increased iron accumulation in their basal ganglia (Figure 18 ). Dominguez et al [75] measured iron accumulation in the basal ganglia in both premanifest and symptomatic Huntington's disease (HD) patients with QSM. Both groups of patients demonstrated substantially elevated iron content in the caudate nucleus, globus pallidus and putamen compared to normal control subjects. In Halefoglu AM et al . SWI of brain diseases creased iron levels showed significant correlation with disease severity (Figure 19 ). QSM is also capable of quantifying elevated iron levels in the motor cortex of amyotrophic lateral sclerosis patients. Furthermore, in Wilson's disease, iron accumulation and quantification can be demonstrated by QSM [71] . Iron chelation therapy in PD can be monitored by QSM [71] . Walsh et al [76] have
shown that the deficits of patients with MS more strongly correlate with QSM values of brain iron content than the MS plaque volume (Figure 20) .
CONCLUSION
SWI is a very useful imaging tool with a variety of ap Figure 20 .
